1st Quarter - Report
AMERICAN ASSOCIATION FOR CANCER RESEARCH for AMERICAN ASSOCIATION FOR CANCER RESEARCH
Income
—
Expenses
$80,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY 2022 Appropriations for the National Institutes of Health FY 2022 Appropriations for the Centers for Disease Control and Prevention
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANA MILLER ACTON New | — |
| MARC JOHNSON | — |
| BRANDON LANE LEONARD | — |
Health Issues HCR
Cancer health disparities HPV-related cancers - prevention, screening, diagnosis and treatment HPV vaccination
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANA MILLER ACTON New | — |
| MARC JOHNSON | — |
| BRANDON LANE LEONARD | — |
Medical/Disease Research/Clinical Labs MED
Cancer research Oncology product review at the FDA Pediatric research and cancer care
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANA MILLER ACTON New | — |
| MARC JOHNSON | — |
| BRANDON LANE LEONARD | — |
Tobacco TOB
Tobacco control measures E-cigarette regulation
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANA MILLER ACTON New | — |
| MARC JOHNSON | — |
| BRANDON LANE LEONARD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.